CorporateActive

CERO repays the consolidated note in full by the October 15 maturity

Does CERo Therapeutics Holdings repay the Consolidated Senior Secured Promissory Note (SRX Global, issued 2026-08-27) in full, principal and accrued interest, on or before its 2026-10-15 maturity, with no extension exercised?

premise not yet verified

EHIQ

15%

(8-25%)

Market

—

Edge

—

Thesis

CERO required monthly working-capital advances at consolidation ($775,665 funded 2026-08-27, more scheduled), so repayment of up to $11.67M plus interest inside 6 weeks requires an external financing event, not operations. Extension costs SRX nothing and sits entirely in SRX's discretion (4 consecutive 30-day periods), keeping 10% accruing and avoiding an enforcement process. The residual 15% is a partnering, raise, or asset event on the CER-1236 program before maturity; a default-and-enforcement path resolves this NO, not YES.

1.repayment needs an external financing event inside 6 weeks
2.extension is free and at SRX's sole discretion
3.enforcement/acceleration resolves this NO early

Opened

September 3, 2026

Expected resolution

October 15, 2026

Get an alert the moment this call resolves.

Every EHIQ call resolves on a date, in public. Subscribe free and we email you when this one grades, plus the weekly divergence leaderboard.